471 related articles for article (PubMed ID: 26838792)
1. The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.
Menazza S; Murphy E
Circ Res; 2016 Mar; 118(6):994-1007. PubMed ID: 26838792
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
3. GPER: a novel target for non-genomic estrogen action in the cardiovascular system.
Han G; Li F; Yu X; White RE
Pharmacol Res; 2013 May; 71():53-60. PubMed ID: 23466742
[TBL] [Abstract][Full Text] [Related]
4. Estrogen signaling: a subtle balance between ER alpha and ER beta.
Matthews J; Gustafsson JA
Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
[TBL] [Abstract][Full Text] [Related]
5. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor subcellular localization and cardiometabolism.
Gourdy P; Guillaume M; Fontaine C; Adlanmerini M; Montagner A; Laurell H; Lenfant F; Arnal JF
Mol Metab; 2018 Sep; 15():56-69. PubMed ID: 29807870
[TBL] [Abstract][Full Text] [Related]
7. Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase.
Simoncini T; Fornari L; Mannella P; Varone G; Caruso A; Liao JK; Genazzani AR
Steroids; 2002 Nov; 67(12):935-9. PubMed ID: 12398989
[TBL] [Abstract][Full Text] [Related]
8. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors.
Coleman KM; Smith CL
Front Biosci; 2001 Oct; 6():D1379-91. PubMed ID: 11578956
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Receptor Functions and Pathways at the Vascular Immune Interface.
Dama A; Baggio C; Boscaro C; Albiero M; Cignarella A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923905
[TBL] [Abstract][Full Text] [Related]
10. Reciprocality Between Estrogen Biology and Calcium Signaling in the Cardiovascular System.
Tran QK
Front Endocrinol (Lausanne); 2020; 11():568203. PubMed ID: 33133016
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen.
Lindsey SH; Chappell MC
Gend Med; 2011 Dec; 8(6):343-54. PubMed ID: 22153880
[TBL] [Abstract][Full Text] [Related]
12. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor signaling mechanisms.
Fuentes N; Silveyra P
Adv Protein Chem Struct Biol; 2019; 116():135-170. PubMed ID: 31036290
[TBL] [Abstract][Full Text] [Related]
14. Membrane-initiated estrogen signaling via Gq-coupled GPCR in the central nervous system.
Vail G; Roepke TA
Steroids; 2019 Feb; 142():77-83. PubMed ID: 29378226
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species.
O'Lone R; Knorr K; Jaffe IZ; Schaffer ME; Martini PG; Karas RH; Bienkowska J; Mendelsohn ME; Hansen U
Mol Endocrinol; 2007 Jun; 21(6):1281-96. PubMed ID: 17374850
[TBL] [Abstract][Full Text] [Related]
16. Non-genomic regulation of vascular cell function and growth by estrogen.
Meyer MR; Haas E; Prossnitz ER; Barton M
Mol Cell Endocrinol; 2009 Sep; 308(1-2):9-16. PubMed ID: 19549587
[TBL] [Abstract][Full Text] [Related]
17. The Role of Estrogen Receptors in Cardiovascular Disease.
Aryan L; Younessi D; Zargari M; Banerjee S; Agopian J; Rahman S; Borna R; Ruffenach G; Umar S; Eghbali M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560398
[TBL] [Abstract][Full Text] [Related]
18. VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha.
Jesmin S; Mowa CN; Sultana SN; Shimojo N; Togashi H; Iwashima Y; Kato N; Sato A; Sakuma I; Hiroe M; Hattori Y; Yamaguchi N; Kobayashi H
Eur J Pharmacol; 2010 Sep; 641(2-3):168-78. PubMed ID: 20639141
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptors and function in the male reproductive system.
Lazari MF; Lucas TF; Yasuhara F; Gomes GR; Siu ER; Royer C; Fernandes SA; Porto CS
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):923-33. PubMed ID: 20126844
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
